Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex vivo efficacy of BCMA-bispecific antibody TNB-383B in relapsed/refractory multiple myeloma.
Foureau DM, Bhutani M, Robinson M, Guo F, Pham D, Buelow B, Steuerwald N, Rigby K, Tjaden E, Leonidas M, Paul BA, Atrash S, Ndiaye A, Symanowski JT, Voorhees PM, Usmani SZ. Foureau DM, et al. Among authors: usmani sz. EJHaem. 2020 Aug 1;1(1):113-121. doi: 10.1002/jha2.69. eCollection 2020 Jul. EJHaem. 2020. PMID: 35847733 Free PMC article.
Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.
Abdallah AO, Atrash S, Shahid Z, Jameel M, Grazziutti M, Apewokin S, Kumar NS, Restrepo A, Waheed S, Van Rhee F, Heuck CJ, Johann D Jr, Barlogie B, Usmani SZ. Abdallah AO, et al. Among authors: usmani sz. Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):211-4. doi: 10.1016/j.clml.2013.11.004. Epub 2013 Nov 16. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24373936
Multiple myeloma: is it time for biomarker-driven therapy?
Bhutani M, Landgren O, Usmani SZ. Bhutani M, et al. Among authors: usmani sz. Am Soc Clin Oncol Educ Book. 2015:e493-503. doi: 10.14694/EdBook_AM.2015.35.e493. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993214 Free article. Review.
Defining and treating high-risk multiple myeloma.
Usmani SZ, Rodriguez-Otero P, Bhutani M, Mateos MV, Miguel JS. Usmani SZ, et al. Leukemia. 2015 Nov;29(11):2119-25. doi: 10.1038/leu.2015.209. Epub 2015 Aug 12. Leukemia. 2015. PMID: 26265183 Review.
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.
Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ, Belch A, Krishnan A, Vescio RA, Mateos MV, Mazumder A, Orlowski RZ, Sutherland HJ, Bladé J, Scott EC, Oriol A, Berdeja J, Gharibo M, Stevens DA, LeBlanc R, Sebag M, Callander N, Jakubowiak A, White D, de la Rubia J, Richardson PG, Lisby S, Feng H, Uhlar CM, Khan I, Ahmadi T, Voorhees PM. Lonial S, et al. Among authors: usmani sz. Lancet. 2016 Apr 9;387(10027):1551-1560. doi: 10.1016/S0140-6736(15)01120-4. Epub 2016 Jan 7. Lancet. 2016. PMID: 26778538 Clinical Trial.
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma.
Usmani SZ, Weiss BM, Plesner T, Bahlis NJ, Belch A, Lonial S, Lokhorst HM, Voorhees PM, Richardson PG, Chari A, Sasser AK, Axel A, Feng H, Uhlar CM, Wang J, Khan I, Ahmadi T, Nahi H. Usmani SZ, et al. Blood. 2016 Jul 7;128(1):37-44. doi: 10.1182/blood-2016-03-705210. Epub 2016 May 23. Blood. 2016. PMID: 27216216 Free PMC article. Clinical Trial.
Practical Considerations in Managing Relapsed Multiple Myeloma.
Agarwal A, Chow E, Bhutani M, Voorhees PM, Friend R, Usmani SZ. Agarwal A, et al. Among authors: usmani sz. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):69-77. doi: 10.1016/j.clml.2016.11.010. Epub 2016 Nov 23. Clin Lymphoma Myeloma Leuk. 2017. PMID: 27986429 Review.
298 results